KATE NATTIER: Open Payments
NPI 1326340720 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 25 payments from 13 companies in 2025. Trend: 2023 $458 · 2024 $532 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $91 |
| Novo Nordisk Inc | 4 | $68 |
| Astellas Pharma US Inc | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| ABBVIE INC. | 2 | $32 |
| Boston Scientific Corporation | 1 | $27 |
| Abbott Laboratories | 1 | $22 |
| Cranial Technologies, Inc | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: SHINGRIX, Veozah, Ozempic, LEQVIO, XIFAXAN, WaveWriter Alpha Prime 16, FREESTYLE LIBRE 3, Doc Band.
Industry payments across SC — which companies pay providers there.
